Next, we showed11 that the induction of PHLDA1 expression by an anti-GD2 ganglioside antibody resulted in decreased levels of aurora A kinase, its activating phosphorylation, and the MYCN oncogene in IMR-32 human neuroblastoma cells. The gene discussed is PHLDA1; the disease is neuroblastoma.